NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men With Clinically Localized Prostate Cancer
About This Trial
- This study is testing a computer program designed to create a clear, simple summary of the most important points discussed during your doctor's visit, such as your treatment options and potential side effects.
- It is open to English-speaking patients at Cedars-Sinai who have localized prostate cancer and are deciding on their next steps for care.
- Within two weeks of your appointment, both you and your doctor will receive this written summary to help you talk through your choices and make decisions together.
- Because this study focuses entirely on improving communication, taking part does not involve any new medications or medical procedures.
More Information
- In this pilot study, the investigators will show feasibility of the NLP-based feedback system in 20 consultations of men with newly diagnosed prostate cancer.
- The investigators will recruit from the practices of up to 10 physicians who typically see these patients.
- The investigators will report the top five sentences from each consultation across key content areas (cancer prognosis, life expectancy, erectile dysfunction, urinary incontinence, and irritative urinary symptoms) to both patients and physicians within 2 weeks of the consultation.
Who Can Enroll
- Age Range: 18 years and older
- Gender: Male
- Who This Trial is For: This study is testing a computer program designed to create a clear, simple summary of the most important points discussed during your doctor's visit, such as your treatment options and potential side effects.
Study Details
- Start Date: November 15, 2023
- Lead Sponsor: Cedars-Sinai Medical Center
Full Eligibility Criteria
Inclusion Criteria
- Men undergoing initial treatment consultation for clinically localized prostate cancer;
- Men with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy.
- Cedars-Sinai patient.
- Ability to read and write in English.
Exclusion Criteria
- Under 18 years of age;
- Subjects with difficulty communicating or dementia;
- Non-English speakers, given that our NLP-based tools cannot be used with languages other than English;
- Men with locally advanced or metastatic prostate cancer;
- Men who have already been treated for clinically localized prostate cancer
Treatments
- Behavioral: NLP-based Feedback